Orexigen Therapeutics Inc. buy melinda
Start price
18.09.10
/
50%
€44.80
Target price
23.12.10
€55.00
Performance (%)
37.28%
End price
23.12.10
€61.50
Summary
This prediction ended on 23.12.10 with a price of €61.50. With a performance of 37.28% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orexigen Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by melinda for this prediction
In the thread Orexigen Therapeutics Inc. diskutieren
Biopharma-
Orexigen Therapeutics ist ein biopharmazeutisches Unternehmen auf die Entwicklung von Medikamenten in der Behandlung von Fettleibigkeit konzentriert
(Vom Mitglied beendet)
Stopped prediction by melinda for Orexigen Therapeutics Inc.
Orexigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.48
18.04.17
18.04.17
€3.61
24.04.17
24.04.17
5.45%
24.04.17
24.04.17
Orexigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.49
05.09.16
05.09.16
€3.83
06.02.17
06.02.17
14.26%
06.02.17
06.02.17